Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

JULIAN CARLOS DE LA TORRE CISNEROS2026-01-292026-01-29202110.1016/S1473-3099(20)30331-52-s2.0-85091905902https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/32362Infectious DiseasesSafety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialresearch article